The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing
暂无分享,去创建一个
David R. Liu | William A. Pastor | A. Rao | Yun Huang | M. Tahiliani | Yinghua Shen | Mamta Tahiliani
[1] K. Patterson,et al. DNA Methylation: Bisulphite Modification and Analysis , 2011, Journal of visualized experiments : JoVE.
[2] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[3] M. Carroll,et al. A common genetic mechanism in malignant bone marrow diseases. , 2009, The New England journal of medicine.
[4] J. Soulier,et al. Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.
[5] Lee E. Edsall,et al. Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.
[6] Anne H. O'Donnell,et al. Mammalian cytosine methylation at a glance , 2009, Journal of Cell Science.
[7] A. Hagemeijer,et al. Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.
[8] C. Mullighan. TET2 mutations in myelodysplasia and myeloid malignancies , 2009, Nature Genetics.
[9] Jungwon Huh,et al. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. , 2009, Blood.
[10] Z. Liutkevičiūtė,et al. Cytosine-5-methyltransferases add aldehydes to DNA. , 2009, Nature chemical biology.
[11] R. Lister,et al. Finding the fifth base: genome-wide sequencing of cytosine methylation. , 2009, Genome research.
[12] David R. Liu,et al. Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .
[13] N. Heintz,et al. The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain , 2009, Science.
[14] E. Thiel,et al. The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group. , 2009, Blood.
[15] D. Gilliland,et al. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML , 2009, Leukemia.
[16] D. Gilliland,et al. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis , 2009, Leukemia.
[17] A. Feinberg,et al. Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.
[18] M. Krzywinski,et al. New insights to the MLL recombinome of acute leukemias , 2009, Leukemia.
[19] D. Gilliland,et al. Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates , 2009, Leukemia.
[20] T. Mikkelsen,et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.
[21] Stephan Beck,et al. The methylome: approaches for global DNA methylation profiling. , 2008, Trends in genetics : TIG.
[22] S. Nelson,et al. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning , 2008, Nature.
[23] Peter A. Jones,et al. Cancer epigenetics: modifications, screening, and therapy. , 2008, Annual review of medicine.
[24] Steven Henikoff,et al. Genome-wide analysis of DNA methylation patterns , 2007, Development.
[25] Christoph Plass,et al. Unraveling the epigenetic code of cancer for therapy. , 2007, Trends in genetics : TIG.
[26] Michael Weber,et al. Genomic patterns of DNA methylation: targets and function of an epigenetic mark. , 2007, Current Opinion in Cell Biology.
[27] W. Reik. Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.
[28] M. Esteller. Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.
[29] L. Sowers,et al. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. , 2007, Cancer research.
[30] S. Doublié,et al. A structural rationale for stalling of a replicative DNA polymerase at the most common oxidative thymine lesion, thymine glycol , 2007, Proceedings of the National Academy of Sciences.
[31] D. Dietrich,et al. Control of carry-over contamination for PCR-based DNA methylation quantification using bisulfite treated DNA , 2006, Nucleic acids research.
[32] Kenny Q. Ye,et al. Comparative isoschizomer profiling of cytosine methylation: the HELP assay. , 2006, Genome research.
[33] A. Bird,et al. Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.
[34] T. Bestor,et al. Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.
[35] A. Bird,et al. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). , 2004, Nucleic acids research.
[36] S. Mathew,et al. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23) , 2003, Leukemia.
[37] Y. Hayashi,et al. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). , 2002, Cancer research.
[38] W. Reik,et al. Epigenetic Reprogramming in Mammalian Development , 2001, Science.
[39] A. Bird,et al. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. DePamphilis,et al. Identifying 5-methylcytosine and related modifications in DNA genomes. , 1998, Nucleic acids research.
[41] J. Clark,et al. Thymine glycol lesions terminate chain elongation by DNA polymerase I in vitro. , 1986, Nucleic acids research.
[42] M. Ehrlich,et al. 5-Methylcytosine in eukaryotic DNA. , 1981, Science.
[43] A. Razin,et al. Methylation of CpG sequences in eukaryotic DNA , 1981, FEBS letters.
[44] H. Hayatsu,et al. Reaction of bisulfite with the 5-hydroxymethyl group in pyrimidines and in phage DNAs. , 1979, Biochemistry.
[45] Y. Wataya,et al. Reaction of sodium bisulfite with uracil, cytosine, and their derivatives. , 1970, Biochemistry.